Key NS - Search Results

1

Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic model.

Zhu J, Wu YS, Beechinor RJ, Kemper R, Bukkems LH, Mathôt RAA, Cnossen MH, Gonzalez D, Chen SL, Key NS, Crona DJ. Zhu J, et al. Among authors: key ns. Haemophilia. 2021 Nov;27(6):974-983. doi: 10.1111/hae.14393. Epub 2021 Aug 17. Haemophilia. 2021. PMID: 34405493 Free PMC article.

2

Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia.

Ashrani AA, Reding MT, Greeno EW, Shet A, Key NS. Ashrani AA, et al. Among authors: key ns. Haemophilia. 2002 Jan;8(1):56-8. doi: 10.1046/j.1365-2516.2002.00573.x. Haemophilia. 2002. PMID: 11886466

3

Iliopsoas haemorrhage in patients with bleeding disorders--experience from one centre.

Ashrani AA, Osip J, Christie B, Key NS. Ashrani AA, et al. Among authors: key ns. Haemophilia. 2003 Nov;9(6):721-6. doi: 10.1046/j.1351-8216.2003.00822.x. Haemophilia. 2003. PMID: 14750939

4

Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor.

Ashrani AA, Reding MT, Shet A, Osip J, Humar A, Lake JR, Key NS. Ashrani AA, et al. Among authors: key ns. Haemophilia. 2004 Nov;10(6):735-7. doi: 10.1111/j.1365-2516.2004.01030.x. Haemophilia. 2004. PMID: 15569170

5

Vascular haemostasis.

Key NS, DE Paepe A, Malfait F, Shovlin CL. Key NS, et al. Haemophilia. 2010 Jul;16 Suppl 5:146-51. doi: 10.1111/j.1365-2516.2010.02313.x. Haemophilia. 2010. PMID: 20590874

6

Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A.

Kempton CL, Abshire TC, Deveras RA, Hoots WK, Gill JC, Kessler CM, Key NS, Konkle BA, Kuriakose P, Macfarlane DE, Bergman G. Kempton CL, et al. Among authors: key ns. Haemophilia. 2012 Sep;18(5):798-804. doi: 10.1111/j.1365-2516.2012.02789.x. Epub 2012 Apr 19. Haemophilia. 2012. PMID: 22512291 Clinical Trial.

7

Guidelines for the management of hemophilia.

Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, Ludlam CA, Mahlangu JN, Mulder K, Poon MC, Street A; Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. Srivastava A, et al. Among authors: key ns. Haemophilia. 2013 Jan;19(1):e1-47. doi: 10.1111/j.1365-2516.2012.02909.x. Epub 2012 Jul 6. Haemophilia. 2013. PMID: 22776238

8

Clinical features and management of haemophilic pseudotumours: a single US centre experience over a 30-year period.

Lim MY, Nielsen B, Ma A, Key NS. Lim MY, et al. Among authors: key ns. Haemophilia. 2014 Jan;20(1):e58-62. doi: 10.1111/hae.12295. Epub 2013 Oct 31. Haemophilia. 2014. PMID: 24354486

9

Rituximab as first-line treatment for the management of adult patients with non-severe hemophilia A and inhibitors.

Lim MY, Nielsen B, Lee K, Kasthuri RS, Key NS, Ma AD. Lim MY, et al. Among authors: key ns. J Thromb Haemost. 2014 Jun;12(6):897-901. doi: 10.1111/jth.12579. J Thromb Haemost. 2014. PMID: 24702722 Free article.

10

Factor VIII inhibitory antibody in a patient with combined factor V/factor VIII deficiency.

Buckner TW, Nielsen BI, Key NS, Ma A. Buckner TW, et al. Among authors: key ns. Haemophilia. 2015 Jan;21(1):e77-80. doi: 10.1111/hae.12557. Epub 2014 Dec 4. Haemophilia. 2015. PMID: 25472918 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters